Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06474520 Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Infl… |
Calculus bovis sativus (CBS) | SEP | Non applicable | RECRUITING | En attente / non publié | Tongji Hospital | China · Tongji Hospital affiliated to Tongji Medical … | 2024-08-08 → 2029-12 | Ouvrir |
| NCT06443333 NIDBase — National, Multicentric Registry Study on Neuroimmunological D… |
NIDBase — National, Multicentric … | SEP | À vérifier | UNKNOWN | En attente / non publié | Xuanwu Hospital, Beijing | China · Xuanwu Hospital ,Capital Medical University, … | 2020-12-01 → 2024-12-30 | Ouvrir |
| NCT00927108 RNASc — Rajavtihi Neuronal Adult Stem Cells Project |
RNASc — Rajavtihi Neuronal Adult … | SEP | Phase 2 | WITHDRAWN | En attente / non publié | Department of Medical Services Mi… | Thailand · Rajavithi Hospital, Bangkok, Thailand | 2009-07 → 2011-12 | Ouvrir |
| NCT05171972 Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment |
Ofatumumab | SEP | À vérifier | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | United States · University of Southern California, Lo… | 2022-01-29 → 2025-07-31 | Ouvrir |
| NCT05341895 Kinesiotape on Balance in With Multiple Sclerosis |
Kinesiotape on Balance in With Mu… | SEP | Non applicable | UNKNOWN | En attente / non publié | Firat University | Turkey (Türkiye) · Fırat university, Elâzığ, Turkey (… | 2021-11-22 → 2022-05-06 | Ouvrir |
| NCT07645703 MS-Health — MS and Health Cohort |
MS-Health — MS and Health Cohort | SEP | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Fondation Ophtalmologique Adolphe… | Non communiqué | 2026-06-11 → 2034-06 | Ouvrir |
| NCT02403947 MESEMS — MEsenchymal StEm Cells for Multiple Sclerosis |
Mesenchymal stem cells | SEP | Phase 1/2 | TERMINATED | En attente / non publié | University Hospital, Toulouse | France · Purpan Hospital, Toulouse, France | 2015-02 → 2017-12 | Ouvrir |
| NCT04977622 Gray Matter Demyelination in Primary Progressive MS at 7T |
Gray Matter Demyelination in Prim… | SEP | À vérifier | UNKNOWN | En attente / non publié | Danish Research Centre for Magnet… | Denmark · Danish Research Centre for Magnetic Resonan… | 2021-11-30 → 2024-12 | Ouvrir |
| NCT02308137 Domperidone in Secondary Progressive Multiple Sclerosis (SPMS) |
Domperidone | SEP | Phase 2 | COMPLETED | En attente / non publié | University of Calgary | Canada · Calgary MS Clinic at Foothills Medical Centr… | 2015-02 → 2020-01-03 | Ouvrir |
| NCT05558683 Effect of the Vojta Therapy in Patients Multiple Sclerosis |
Effect of the Vojta Therapy in Pa… | SEP | Non applicable | UNKNOWN | En attente / non publié | Aymara Abreu Corrales | Non communiqué | 2022-12-01 → 2023-12-01 | Ouvrir |
| NCT00781872 Mesenchymal Stem Cells for the Treatment of MS |
Injection of autologous bone marr… | SEP | Phase 1/2 | COMPLETED | En attente / non publié | Hadassah Medical Organization | Non communiqué | 2006-10 → 2009-12 | Ouvrir |
| NCT05532943 UMSC01 — Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord … |
Allogeneic umbilical cord mesench… | SEP | Phase 1/2 | RECRUITING | En attente / non publié | Ever Supreme Bio Technology Co., … | Taiwan · China Medical University Hospital, Taichung,… | 2023-09-08 → 2028-10-31 | Ouvrir |
| NCT00559702 Safety Study of Natalizumab to Treat Multiple Sclerosis (MS) |
natalizumab | SEP | Phase 1 | COMPLETED | En attente / non publié | Biogen | United States · Research Site, Berkeley, United State… | 2007-10 → 2011-11 | Ouvrir |
| NCT03774407 Vaginal Estriol in Multiple Sclerosis |
vaginal estriol | SEP | Phase 2/3 | COMPLETED | En attente / non publié | Texas Tech University Health Scie… | United States · Texas Tech University Health Sciences… | 2019-06-20 → 2020-11-29 | Ouvrir |
| NCT01220830 RFQMR — Cytotron® Delivered Rotational Field Quantum Nuclear Magnetic R… |
Cytotron | SEP | Phase 2 | UNKNOWN | En attente / non publié | The Centre for Advanced Research … | India · Centre for Advanced Research and Development,… | 2010-09 → 2011-12 | Ouvrir |
| NCT04909502 Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 … |
EHP-101 25 mg OD | SEP | Phase 2 | SUSPENDED | En attente / non publié | Emerald Health Pharmaceuticals | United States, Australia · Accel Research Sites - Bra… | 2021-10-19 → 2024-04 | Ouvrir |
| NCT01808885 MSREPAIR — Safety Study of Olesoxime in Patients With Stable Relapsing … |
olesoxime (TRO19622) | SEP | Phase 1 | COMPLETED | En attente / non publié | Hoffmann-La Roche | France · CHU Pontchaillou, Neurology Department, Renn… | 2013-04 → 2014-01 | Ouvrir |
| NCT01244139 Safety Study of BIIB033 in Subjects With Multiple Sclerosis |
BIIB033 | SEP | Phase 1 | COMPLETED | En attente / non publié | Biogen | United States · Research Site, Centennial, United Sta… | 2010-10 → 2012-04 | Ouvrir |
| NCT02087631 Safety and Tolerability of Quetiapine in Multiple Sclerosis |
Extended-release quetiapine fumar… | SEP | Phase 1/2 | COMPLETED | En attente / non publié | University of Calgary | Canada · MS Clinic, Foothills Medical Centre, Calgary… | 2014-12 → 2019-07 | Ouvrir |
| NCT02649985 MAPET — PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, a… |
[F-18]PBR06 | SEP | Phase 1/2 | RECRUITING | En attente / non publié | Brigham and Women's Hospital | United States · Brigham MS Center, 60 Fenwood Road, B… | 2016-05-02 → 2027-12-31 | Ouvrir |
| NCT04626921 VISIONMS-LTE — A Multi-Center, Open-Label Long-Term Extension Study of … |
CNM-Au8 | SEP | Phase 2/3 | COMPLETED | En attente / non publié | Clene Nanomedicine | Australia · John Hunter Hospital, New Lambton Heights… | 2020-10-22 → 2023-09-06 | Ouvrir |
| NCT05834855 Noisy Rebels — Non-inferiority Study of Rituximab Compared to Ocrelizum… |
Rituximab | SEP | Phase 3 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | Netherlands · Amsterdam UMC, location VUmc, Amsterdam… | 2023-04 → 2027-05 | Ouvrir |
| NCT02545868 A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In P… |
23-PPV | SEP | Phase 3 | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States, Canada · Abington Neurological Associa… | 2015-10-27 → 2021-09-21 | Ouvrir |
| NCT06586177 REBELLION-MS — Understanding the 'Durable Effect' Concept of B-cell Mod… |
Anti-CD20 antibody | SEP | À vérifier | RECRUITING | En attente / non publié | Heinrich-Heine University, Duesse… | Germany · Heinrich-Heine University, Duesseldorf, Düs… | 2021-10-27 → 2028-12-31 | Ouvrir |
| NCT05266469 Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in … |
Exploring the Profiles of RMS Pat… | SEP | À vérifier | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | United Arab Emirates · Novartis Investigative Site, A… | 2022-07-26 → 2024-11-11 | Ouvrir |